Trade MerckCo USA ^MRK

OFI Invest Asset Management Sells 27,934 Shares of Merck & Co., Inc. $MRK

Newman Dignan & Sheerar Inc. Trims Stake in Merck & Co., Inc. $MRK

Jackson Square Capital LLC Acquires Shares of 9,701 Merck & Co., Inc. $MRK

Franklin Street Advisors Inc. NC Grows Position in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Sold by Addenda Capital Inc.

Jackson Square Capital LLC Invests $1.02 Million in Merck & Co., Inc. $MRK - Daily Political

Assessing Merck (MRK) Valuation After Strong Recent Share Price Momentum

J&J introduces Varipulse Pro to Europe after CE mark | BioWorld

Merck & Co., Inc. $MRK Shares Sold by Yousif Capital Management LLC

19,470 Shares in Merck & Co., Inc. $MRK Acquired by Jefferson Bridge Capital LLC

Merck & Co., Inc. $MRK Stock Holdings Lowered by Yousif Capital Management LLC - Stock Observer

MBL Wealth LLC Purchases 5,316 Shares of Merck & Co., Inc. $MRK - Daily Political

Merck (MRK) Stock Declines While Market Improves: Some Information for Investors

Is Merck & Co. (MRK) One of the Best Consistent Dividend Stocks to Buy Right Now?

Strong Results Lifted Merck & Co (MRK) in Q4

Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho

Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Rathbones Group PLC Trims Stock Position in Merck & Co., Inc. $MRK - Zolmax

Merck & Co., Inc. $MRK Shares Sold by Rathbones Group PLC

Merck & Co., Inc. $MRK Shares Bought by Quilter Plc

Merck & Co., Inc. $MRK Shares Purchased by Savvy Advisors Inc.

Assessing Merck (MRK) Valuation After Keytruda EU Approval And Strong Oral PCSK9 Phase 3 Results

Analysts Conflicted on These Healthcare Names: Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO) | Markets Insider

Nvwm LLC Acquires 31,854 Shares of Merck & Co., Inc. $MRK

JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Stock Position Trimmed by Florida Trust Wealth Management Co

Philip James Wealth Mangement LLC Has $19.47 Million Stake in Merck & Co., Inc. $MRK - Markets Daily

Hanson & Doremus Investment Management Sells 10,871 Shares of Merck & Co., Inc. $MRK

Perpetual Ltd Purchases 9,261 Shares of Merck & Co., Inc. $MRK

Tritonpoint Wealth LLC Has $6.74 Million Stock Holdings in Merck & Co., Inc. $MRK - Daily Political

Erste Group Sticks to Its Hold Rating for Merck & Company (MRK) | Markets Insider

West Branch Capital LLC Sells 15,875 Shares of Merck & Co., Inc. $MRK

Howard Capital Management Group LLC Sells 7,928 Shares of Merck & Co., Inc. $MRK - Markets Daily

Eldred Rock Partners LLC Has $11.31 Million Stake in Merck & Co., Inc. $MRK

10,200 Shares in Merck & Co., Inc. $MRK Purchased by FNY Investment Advisers LLC

16,300 Shares in Merck & Co., Inc. $MRK Purchased by Dorato Capital Management

Merck & Co., Inc. $MRK Shares Bought by Aberdeen Group plc

Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market Intelligence Report 2026-2030: Industry Growth Driven by Personalized Treatment Adoption

Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry

Next-Gen Oncology Devices and Solutions Market to Double by 2030, Reaching Over $38 Billion

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

Head and Neck Squamous Cell Carcinoma Market Forecast to 2030 & 2035

Tema Etfs LLC Raises Stock Holdings in Merck & Co., Inc. $MRK

Merck & Co., Inc.'s (MRK) "Outperform" Rating Reiterated at Royal Bank Of Canada - Zolmax

Merck & Co., Inc. $MRK Shares Sold by Banque Pictet & Cie SA

Bank Pictet & Cie Europe AG Lowers Stake in Merck & Co., Inc. $MRK

Merck (MRK) Reports Strong Phase 3 Results for Oral PCSK9

Merck & Co., Inc. $MRK Shares Sold by Highline Wealth Partners LLC

Merck & Co., Inc. $MRK Shares Bought by Moody Lynn & Lieberson LLC

Shrier Wealth Management LLC Buys New Position in Merck & Co., Inc. $MRK

Advanced Renal Cell Carcinoma Treatment Market to Grow by $3.1 Billion During 2026-2030: Global Industry Assessment Featuring Pfizer, Merck & Co., Bristol-Myers Squibb, AstraZeneca, Novartis and More

Econ Financial Services Corp Sells 8,757 Shares of Merck & Co., Inc. $MRK

Nisa Investment Advisors LLC Increases Holdings in Merck & Co., Inc. $MRK - Daily Political

Why is Merck & Co. (MRK) One of the Best Affordable Stocks to Buy With Good Earnings Growth?

Westend Capital Management LLC Boosts Holdings in Merck & Co., Inc. $MRK

Lupin gets USFDA tentative nod for Sugammadex Injection

Neostigmine versus sugammadex on outpatient recovery among obese patients with obstructive sleep apnea: A randomized controlled trial

Merck & Co., Inc. (NYSE:MRK) Upgraded at Wall Street Zen - Daily Political

Merck & Co., Inc. (NYSE:MRK) Receives "Outperform" Rating from Royal Bank Of Canada

The Phase 3 CORALreef AddOn trial compared the efficacy and

Merck (MRK) Shares Up Significantly Since Jim Cramer Advised to "Stay the Course"

Merck & Co., Inc. $MRK Holdings Decreased by R.H. Dinel Investment Counsel Inc.

$1.59 Billion PD-1 Resistant Head and Neck Cancer Market Analysis Report 2026: Size, Growth, and Segmentation Insights to 2030

Advanced Melanoma Markets and Companies 2026-2030: Cumulative Revenue to Grow by $1.87 Billion

Cutaneous Squamous Cell Carcinoma (cSCC) Market Rises to $8.33 Billion in 2026: Roche, Merck & Co., and Sanofi Leads the Industry

Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline

Paraganglioma Market Trends and Investment Opportunities 2026-2030

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 - Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million

Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030

Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

Merck's WINREVAIR met primary endpoint of change in pulmonar

Merck & Co., Inc. $MRK Stock Holdings Cut by Hunter Perkins Capital Management LLC

Assessing Merck (MRK) Valuation After Mixed Recent Returns And Keytruda Patent Uncertainty

Cypress Wealth Services LLC Purchases 9,854 Shares of Merck & Co., Inc. $MRK

Eastern Bank Sells 10,373 Shares of Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Sold by Advisors Management Group Inc. ADV

Merck & Co., Inc. $MRK Shares Bought by LVW Advisors LLC - Daily Political

Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion

Exchange Traded Concepts LLC Buys 219,579 Shares of Merck & Co., Inc. $MRK

Merck & Co. Touts $6.7B Terns Deal, Highlights TERN-701 "Best-in-Class" CML Potential

Merck & Co., Inc. (NYSE:MRK) Raised to "Buy" at Wall Street Zen

Exchange Traded Concepts LLC Has $33.13 Million Stock Position in Merck & Co., Inc. $MRK - Stock Observer

Jim Cramer on Merck & Co.: "If We're Really Going Into an Oil Shock-Induced Slowdown, I Think This One's Likely an Outperformer""

Global X Japan Co. Ltd. Takes Position in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Sold by Synergy Asset Management LLC

What is Erste Group Bank's Estimate for MRK FY2026 Earnings? - Stock Observer

Merck & Co., Inc. $MRK Shares Acquired by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH Raises Stock Position in Merck & Co., Inc. $MRK - Stock Observer

RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over "Modest Premium"